Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for Reducing Blood Loss During Myomectomy
NCT07746349Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Dec 2026
01
Overview
Randomised, double-blind trial in uterine fibroid comparing Terlipressin Group with Placebo Group (2 arms). Primary endpoint: Intraoperative Blood Loss. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
terlipressin
03
Conditions
uterine fibroid
Beyond the preview
Go deeper on NCT07746349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746349.